SIDE-BY-SIDE EVIDENCE
Compare evidence.
Keep the context.
Select 2–3 profiles from the English Library. Class and grade describe evidence and regulatory context, not comparative effectiveness or suitability for an individual.
Choose profilesSIDE-BY-SIDE EVIDENCE VIEW
Compare selected profiles
| Molecule |  Salbutamol / Albuterol | Clenbuterol | Prednisone |
|---|---|---|---|
| Research Topic | Clinical / Endocrine Pharmacology | Clinical / Endocrine Pharmacology | Clinical / Endocrine Pharmacology |
| Pharmacology | Short-acting beta-2 adrenergic agonist medicine | Long-acting beta-2 adrenergic agonist not FDA-approved for human use | Systemic glucocorticoid prodrug medicine |
| PrimeCore Class | Class AApproved in a bounded context | Class BInvestigational | Class AApproved in a bounded context |
| Evidence Grade | Grade AStrong regulatory + clinical evidence | Grade EPreclinical evidence | Grade AStrong regulatory + clinical evidence |
| Evidence boundary | Salbutamol / Albuterol is classified here as Short-acting beta-2 adrenergic agonist medicine. Strong clinical evidence applies to authorised inhaled products and respiratory indications, not catalogue tablets for weight loss or performance. FDA-authorised respiratory products exist; WADA permits only specified inhaled salbutamol conditions and thresholds, while other routes/use are prohibited. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions. | Clenbuterol is classified here as Long-acting beta-2 adrenergic agonist not FDA-approved for human use. Human misuse reports and veterinary/regulatory records are more relevant than performance claims; no FDA-approved human product exists. Not FDA-approved for human use; prohibited by WADA under beta-2 agonists at all times except narrowly specified permitted inhaled medicines that do not include clenbuterol. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions. | Prednisone is classified here as Systemic glucocorticoid prodrug medicine. Extensive prescription evidence applies to disease-specific regimens and monitoring, not general recovery or performance use. FDA-authorised prescription products exist; WADA prohibits systemic glucocorticoids in competition by specified routes and requires current rule checking. A catalogue name does not establish identity, formulation, quality or authorisation, and this page provides no dosage, mixing, injection or purchasing instructions. |
| Unknowns | Insufficient data in the current dataset | Insufficient data in the current dataset | Insufficient data in the current dataset |
| Limitations |
|
|
|
| Sources | |||
| Read more | Read English overview | Read English overview | Read English overview |
This table does not compare doses, cross-trial outcomes or individual suitability. Missing information does not establish an absence of risk.
Choose another comparisonContinue reading
Missing fields mean information is unavailable in the current structured dataset, not that a molecule has no risks or uncertainties. English translations retain the original evidence boundaries. Where translation is not yet verified, the original Thai excerpts remain available under an explicit label. Sources retain their original language.
10 questions before drawing conclusions